Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

Menopause can cause hair loss in women due to hormonal changes, affecting their well-being and quality of life.

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Accurate prediction of eye, hair, and skin color in Latin American populations requires region-specific models and ethical guidelines.

Nanocarriers can improve antioxidant delivery to the skin but face safety and production challenges.

New understanding and treatments for hair loss are improving, but more research is needed.

PRP injections improved facial aesthetics in most women, but more research is needed.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Oral and topical finasteride are effective and safe for treating female hair loss.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

PCOS causes inflammation regardless of body weight.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.